Streetbeat News

Stock Prices

PHX

PHX Minerals (NYSE:PHX) reported Q1 earnings with an EPS of $0.07, surpassing the estimate of $0.04 by 75.0%. However, revenue decreased by $6.49 million compared to the same period last year. The company's past earnings performance shows a mixed track record, with a notable 5.0% share price drop following last quarter's earnings miss.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 8:25 pm

MXCT

MaxCyte shares surged following the announcement of their Q4 financial results, which exceeded expectations. Additionally, the company provided positive guidance for FY24.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:24 pm

SKIN

Beauty Health shares surged following the announcement of their Q4 revenue results, which exceeded market expectations.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:23 pm

SWIM

Latham Group (NASDAQ:SWIM) reported Q4 earnings, beating estimated earnings by 100% with an EPS of $0.0 vs. an estimate of $-0.06. However, revenue was down $17.06 million from the same period last year. In the previous quarter, the company missed EPS estimates which led to a 10% drop in share price the following day.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 8:20 pm

BIRD

Allbirds (NASDAQ:BIRD) reported Q4 earnings with a significant miss on estimated earnings by -61.0%, posting an EPS of $-0.37 against an estimate of $-0.23. Revenue also saw a decline, down $12.19 million from the same period last year. This follows a pattern of past earnings performance where a beat on EPS in the previous quarter led to a 24.0% drop in share price the next day.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 8:20 pm

BIRD

Allbirds (NASDAQ:BIRD) reported Q4 2023 earnings with a GAAP EPS of $(0.37), missing the $(0.23) estimate by 60.87%, and a 117.65% decrease from last year. Sales were $71.990M, beating the $69.058M estimate by 4.25%, but down 14.48% from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:18 pm

VJET

Voxeljet AG (VJET) announced plans to voluntarily delist its ADSs from NASDAQ and deregister its ADS with the SEC to reduce expenses and strengthen its financial position. The company believes the costs and management demands of NASDAQ listing and SEC compliance do not justify the benefits. The delisting process will start with a Form 25 filing around March 22, 2024, followed by a Form 15 filing to deregister from the Exchange Act, with deregistration expected around April 1, 2024.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:18 pm

INTC

The Pentagon has decided to cancel its plan to allocate $2.5 billion in grants to Intel for semiconductor chip development, according to Bloomberg.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:18 pm

CLSD

Clearside Biomedical (NASDAQ:CLSD) reported Q4 2023 adjusted EPS of $(0.08), surpassing the $(0.09) estimate, with sales of $6.30M exceeding the $4.43M estimate, marking a 1.81K% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:17 pm

VJET

Trading of Voxeljet AG (VJET) shares has been temporarily halted due to pending news under the 'Code News' category. This action indicates that significant information affecting the company is about to be released, which could impact its stock price once trading resumes.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:16 pm